Articles
14 de February de 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.
Last related news
14 de September de 2026
Guidance Note: Brazil – Direct Marketing
Partner Claudio Barbosa and Attorney at Law Larissa Martins have recently authored the article “Data Guidance: Brazil – Direct Marketing” for the … Guidance Note: Brazil – Direct Marketing
8 de July de 2026
SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
ABSTRACT: The increasing judicialization of disputes involving Standard Essential Patents (SEPs) has shifted the focus of legal debate beyond the mere assessment … SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
28 de January de 2026
Data Protection Day: Between Regulatory Maturity and the New Challenges of Artificial Intelligence
Data Protection Day, celebrated on January 28, goes beyond symbolism. Each year, the date reinforces the consolidation of personal data protection, with … Data Protection Day: Between Regulatory Maturity and the New Challenges of Artificial Intelligence